AdvisorShares Investments LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1425930 BETHESDA, MD

Position in VTGN

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$157,952

-$7,172 QoQ

Shares Held

277,110

+10.8% QoQ

Ownership

0.675%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AdvisorShares Investments LLC holds $17,592,416 across 20 Biotechnology names. VTGN ranks #18 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RLMD	Relmada Therapeutics, Inc.	295,872	$2,059,269
2	ATAI	AtaiBeckley Inc.	567,587	$2,009,257
3	DFTX	Definium Therapeutics, Inc.	91,301	$1,725,588
4	ASND	Ascendis Pharma A/S	5,750	$1,315,197
5	ABVX	Abivax S.A.	11,802	$1,314,152
6	DBVT	DBV Technologies S.A.	50,340	$1,051,602
7	GHRS	GH Research PLC	67,034	$942,498
8	HELP	Cybin Inc.	195,604	$938,899

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$157,952	277,110	+10.8%	Shares	Sole	2026-04-28
2025-12-31	$165,124	250,188	+20.9%	Shares	Sole	2026-02-10
2025-09-30	$734,842	206,998	+1.9%	Shares	Sole	2025-11-05
2025-06-30	$406,228	203,114	+27.7%	Shares	Sole	2025-08-04
2025-03-31	$397,785	159,114	+59.4%	Shares	Sole	2025-05-13
2024-12-31	$294,439	99,810	+47.3%	Shares	Sole	2025-02-14
2024-09-30	$204,017	67,780	+30.9%	Shares	Sole	2024-11-14
2024-06-30	$180,194	51,780	-28.2%	Shares	Sole	2024-08-07
2024-03-31	$380,534	72,071	+32.7%	Shares	Sole	2024-05-14
2023-12-31	$279,158	54,311	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.